Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs
While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developing new breast cancers, a new computer modeling study has shown that these treatments could also reduce the risk of dying from the disease in women who are at high risk.
Read Original Article: Women with elevated breast cancer risk could see mortality benefit from estrogen-blocking drugs »
